Moderna Inc. (MRNA): Price and Financial Metrics
MRNA Price/Volume Stats
| Current price | $68.28 | 52-week high | $170.47 |
| Prev. close | $69.68 | 52-week low | $62.55 |
| Day low | $65.55 | Volume | 11,969,000 |
| Day high | $68.58 | Avg. volume | 4,235,862 |
| 50-day MA | $95.88 | Dividend yield | N/A |
| 200-day MA | $106.16 | Market Cap | 26.17B |
MRNA Stock Price Chart Interactive Chart >
Moderna Inc. (MRNA) Company Bio
Moderna, Inc. (/məˈdɜːrnə/ mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response. (Source:Wikipedia)
Latest MRNA News From Around the Web
Below are the latest news stories about MODERNA INC that investors may wish to consider to help them evaluate MRNA as an investment opportunity.
Tech Stalls As Rising Bond Yields Spook InvestorsIt's been an inauspicious start to the 2024 trading year, with all three major indexes in the red midday. |
The Biggest Losers in S&P 500 This Year: Dollar General, Moderna, and MoreThe five worst performers in the market benchmark so far this year could be set for brighter futures. |
Walgreens, Nike, Moderna: Bargain hunting stocksThe most recent bull market run has been widely described as "weird," with several household stocks underperforming during the bull run on S&P 500 (^GSPC) components. Yahoo Finance Reporter Madison Mills showcases three of these companies — Moderna (MRNA), Walgreens (WBA), and Nike (NKE) — where investors may find the most value for a bargain price on the stocks. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. |
S&P 500 Is Nearing a Record High. This Could Derail It in 2024.Microsoft and OpenAI are sued by the New York Times for copyright infringement, Amazon plans to launch adverts on Prime Video next month, and other news to start your day. |
The Winners and Losers: 2023 Stock Market Performance ReviewThe 2023 stock market saw steep declines followed by rapid upswings, but we're ending the year on a high note (even if some stocks aren't). |
MRNA Price Returns
| 1-mo | -21.37% |
| 3-mo | -48.77% |
| 6-mo | -33.76% |
| 1-year | -40.41% |
| 3-year | -84.12% |
| 5-year | 284.03% |
| YTD | -31.34% |
| 2023 | -44.63% |
| 2022 | -29.28% |
| 2021 | 143.11% |
| 2020 | 434.10% |
| 2019 | 28.09% |
Loading social stream, please wait...